Tibet Weixinkang Medicine Co., Ltd. (SHA:603676)

Tibet Weixinkang Medicine Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	1,134	1,136	1,300	1,323	1,399	1,034
Revenue Growth	-9.52%	-12.65%	-1.70%	-5.43%	35.30%	44.43%
Gross Profit Gross Profit Growth	678.33	693.34	695.98	671.41	726.48	530.92
Operating Income Operating Income Growth	226.76	219.67	222.43	145.07	154.54	92.92
Net Income Net Income Growth	193	232.85	246.17	214.02	176.96	95.91
Earnings Per Share EPS Growth	0.45	0.54	0.57	0.50	0.41	0.23
EPS Growth	-26.59%	-5.26%	14.00%	21.95%	78.26%	64.29%

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	1,065	982.22	1,019	894.75	806.32	711.55
Total Debt Total Debt Growth	11.05	11.2	5.27	7.68	5.79	4.81
Net Cash (Debt) Net Cash Growth	1,054	971.02	1,014	887.07	800.53	706.73
Net Cash Growth	2.78%	-4.25%	14.33%	10.81%	13.27%	22.80%
Net Cash Per Share Net Cash Per Share Growth	2.45	2.25	2.35	2.07	1.85	1.69

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	243.82	185.53	372.78	241.12	246.15	170.69
Capital Expenditures CapEx Growth	-86.49	-83.92	-58.18	-70.81	-77.69	-55.6
Free Cash Flow Free Cash Flow Growth	157.33	101.62	314.61	170.3	168.46	115.09
Free Cash Flow Growth	-27.33%	-67.70%	84.73%	1.09%	46.37%	45.04%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	59.82%	61.05%	53.53%	50.76%	51.95%	51.37%
Operating Margin	20.00%	19.34%	17.11%	10.97%	11.05%	8.99%
Pretax Margin	21.46%	24.97%	21.27%	16.32%	13.04%	11.05%
Profit Margin	17.02%	20.50%	18.93%	16.18%	12.65%	9.28%
FCF Margin	13.88%	8.95%	24.20%	12.88%	12.04%	11.13%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.327	0.327	0.342	0.285	0.235	0.160
Dividend Per Share Growth	-4.39%	-4.39%	20.00%	21.28%	46.88%	68.42%
Dividend Yield	3.59%	3.18%	3.62%	3.02%	1.66%	1.97%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	20.46	19.53	17.59	21.21	39.15	42.23
P/FCF Ratio	25.23	44.76	13.76	26.65	41.12	35.20
PS Ratio	3.50	4.01	3.33	3.43	4.95	3.92

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error